These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 318795)

  • 21. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
    Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV
    Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure.
    Jezek V; Jezková J; Michaljanic A; Niederle P; Feuereisl R
    Eur Heart J; 1990 Dec; 11(12):1059-64. PubMed ID: 2292252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of high-dose sustained-action oral isosorbide dinitrate in stable angina.
    Udhoji VN; Heng MK
    Am J Med; 1984 Feb; 76(2):234-40. PubMed ID: 6364805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism.
    Lewis BS; Hardoff R; Halon DA
    Clin Cardiol; 1989 Sep; 12(9):514-20. PubMed ID: 2791373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K; Koretsune Y; Nanto S; Taniura K
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure.
    Ren JH; Unverferth DV; Magorien RD; Leier CV
    Arch Intern Med; 1985 Apr; 145(4):641-4. PubMed ID: 3985726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
    Unger P; Vachiery JL; de Cannière D; Staroukine M; Berkenboom G
    Am Heart J; 1994 Sep; 128(3):557-63. PubMed ID: 8074020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood pressure management during aortic surgery: urapidil compared to isosorbide dinitrate.
    Van Hemelrijck J; Waets P; Van Aken H; Lacroix H; Nevelsteen A; Suy R
    J Cardiothorac Vasc Anesth; 1993 Jun; 7(3):273-8. PubMed ID: 8518372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic action of nicorandil in chronic congestive heart failure.
    Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
    Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New aspects of the treatment of left ventricular failure: Nitroglycerin (author's transl)].
    Bussmann WD
    Med Klin; 1975 Oct; 70(42):1697-1706. PubMed ID: 810653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressures in survivors with advanced heart failure.
    Steimle AE; Stevenson LW; Chelimsky-Fallick C; Fonarow GC; Hamilton MA; Moriguchi JD; Kartashov A; Tillisch JH
    Circulation; 1997 Aug; 96(4):1165-72. PubMed ID: 9286945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative hemodynamic effects of placebo and oral isosorbide dinitrate in patients with significant coronary artery disease.
    Kasparian H; Wiener L; Duca PR; Gottlieb RS; Brest AN
    Am Heart J; 1975 Jul; 90(1):68-74. PubMed ID: 1094819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isosorbide dinitrate in acute and chronic heart failure.
    Venkataraman K; Durairaj SK; de Guzman M; Haywood LJ
    Clin Pharmacol Ther; 1979 Jan; 25(1):43-50. PubMed ID: 758242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of the vasodilator drug isosorbide dinitrate on ocular circulation.
    Hessemer V; Schmidt KG
    Arch Ophthalmol; 1997 Mar; 115(3):324-7. PubMed ID: 9076203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamic effects of vasodilators and long-term response in heart failure.
    Franciosa JA; Dunkman WB; Leddy CL
    J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.